Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, September 16, 2015 11:03:20 AM
bullish
## source: finance.yahoo.com
Wed, 16 Sep 2015 14:05:21 GMT ~ Intra-Cellular Shares Continue to Climb on Positive Results
read full: http://finance.yahoo.com/news/intra-cellular-shares-continue-climb-140521185.html
*********************************************************
Wed, 16 Sep 2015 10:10:29 GMT ~ INTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/150916/itci8-k.html
*********************************************************
Wed, 16 Sep 2015 10:09:13 GMT ~ Intra-Cellular Therapies Announces Positive Top-Line Results From the First Phase 3 Trial of ITI-007 in Patients With Schizophrenia and Confirms the Unique Pharmacology of ITI-007 in a Separate Positron Emission Tomography Study
[at noodls] - ITI-007 60 mg once-daily met the primary and key secondary efficacy endpoints in the Phase 3 trial ITI-007 60 mg significantly improved social functioning as measured by the Personal and Social Performance ...
read full: http://www.noodls.com/view/A672B649BE684E979B1A58D45320929263B95CA9
*********************************************************
Wed, 16 Sep 2015 10:01:00 GMT ~ 6:01 am Intra-Cellular Therapies announces positive top-line results from its first Phase 3 trial of ITI-007, in patients with schizophrenia: 60 mg once-daily met primary and key secondary endpoints
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#itci
*********************************************************
Wed, 16 Sep 2015 10:00:00 GMT ~ Intra-Cellular Therapies Announces Positive Top-Line Results From the First Phase 3 Trial of ITI-007 in Patients With Schizophrenia and Confirms the Unique Pharmacology of ITI-007 in a Separate Positron Emission Tomography Study
[GlobeNewswire] - Intra-Cellular Therapies to Host a Conference Call Today at 8:30 a.m. ET to Discuss Results
read full: http://finance.yahoo.com/news/intra-cellular-therapies-announces-positive-100000461.html
*********************************************************
$ITCI charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ITCI company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ITCI/company-info
Ticker: $ITCI
OTC Market Place: Not Available
CIK code: 0001567514
Company name: Intra-Cellular Therapies Inc.
Company website: http://www.intracellulartherapies.com
Incorporated In: DE, USA
$ITCI share structure
## source: otcmarkets.com
Market Value: $915,318,583 a/o Sep 15, 2015
Shares Outstanding: 35,056,246 a/o Aug 04, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$ITCI extra dd links
Company name: Intra-Cellular Therapies Inc.
Company website: http://www.intracellulartherapies.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ITCI+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ITCI+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ITCI+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ITCI/news - http://finance.yahoo.com/q/h?s=ITCI+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ITCI/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ITCI/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ITCI+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ITCI
DTCC (dtcc.com): http://search2.dtcc.com/?q=Intra-Cellular+Therapies+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Intra-Cellular+Therapies+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Intra-Cellular+Therapies+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.intracellulartherapies.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.intracellulartherapies.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.intracellulartherapies.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ITCI
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001567514&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ITCI/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ITCI/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ITCI&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ITCI
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ITCI/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ITCI+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ITCI+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ITCI
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ITCI
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ITCI+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ITCI/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ITCI+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ITCI.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ITCI
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ITCI/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ITCI/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ITCI
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ITCI
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ITCI:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ITCI
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ITCI
$ITCI DD Notes ~ http://www.ddnotesmaker.com/ITCI
Recent ITCI News
- Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress • GlobeNewswire Inc. • 09/23/2024 12:00:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2024 09:43:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 10:01:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/30/2024 08:06:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/29/2024 08:34:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 10:00:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/28/2024 08:34:37 PM
- Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences • GlobeNewswire Inc. • 08/28/2024 12:00:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/27/2024 08:22:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/26/2024 08:36:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 10:00:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 08:14:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2024 08:09:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/21/2024 08:25:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 10:03:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/16/2024 08:04:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 10:01:19 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 10:00:17 PM
- Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference • GlobeNewswire Inc. • 08/08/2024 12:00:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 11:55:30 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:49:01 AM
- Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer • GlobeNewswire Inc. • 08/07/2024 11:40:54 AM
- Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance • GlobeNewswire Inc. • 08/07/2024 11:30:38 AM
- Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast • GlobeNewswire Inc. • 07/24/2024 12:00:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 10:02:46 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM